You are here

SAB Biotherapeutics Reports Positive Results from COVID Drug SAB-185

Primary tabs

Wed, 2023-04-26 10:27 — mike kraft

SAB Biotherapeutics Sees Positive Results from COVID Drug SAB-185 By Exec Edge Editorial Staff SAB Biotherapeutics (Nasdaq: SABS) said it saw positive results from a Phase 3 clinical trial that assessed its Covid-19 drug, SAB-185, in non-hospitalized people who were at high-risk for severe outcomes. SAB-185 demonstrated benefit in sustained symptom resolution in study participants with Covid-19 caused by Omicron as compared to participants […] Yahoo Finance

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Page loaded in 1.453 seconds.